A weekly round-up of online education and webinars in aesthetics
The Committees of Advertising Practice (CAP) and Medicines and Healthcare products Regulatory Agency (MHRA) have issued an Enforcement Notice to the beauty and cosmetic services industry urging businesses to review adverts and make immediate changes.
A survey has indicated that only 22.5% of practitioners follow the recommended protocol for treating headaches with botulinum toxin.
An Instagram influencer has been accused of offering dermal fillers to an undercover reporter during COVID-19 lockdown.
Global biopharmaceutical company AbbVie has completed its acquisition of Allergan plc following regulatory approval of all government authorities.
The London Academy of Aesthetic Medicine has launched The Online Ultimate Toxin Course.
London-based aesthetic practitioner Dr Vincent Wong interviews Beijing-based Dr Hu Jin Tian on how his clinic is coping following the outbreak of coronavirus
An Enforcement Notice on January 31 highlighting the rules and concerns around botulinum toxin advertising and other prescription-only medicines on social media has prompted a surge of enquiries to the Advertising Standards Authority (ASA).
Specialist law firm Cosmetic Surgery Solicitors has teamed up with government-approved register of accredited practitioners, Save Face, to caution would-be patients about discounted injectable treatments.
New technology will be in place from January 31 to monitor advertisements on social media relating to the promotion of prescription-only medicines (POMs) such as botulinum toxin.